Wellington Shields & Co., LLC Eli Lilly & CO Transaction History

Wellington Shields & Co., LLC

$303 Million
Q2 2024

A detailed history of Wellington Shields & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 13,536 shares of LLY stock, worth $11.9 Million. This represents 4.04% of its overall portfolio holdings.

Number of Shares

13,536

Previous 13,732 1.43%

Holding current value

$11.9 Million

Previous $10.7 Million 14.73%

% of portfolio

4.04%

Previous 3.61%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $142,074 - $178,171	-196 Reduced 1.43%	13,536 $12.3 Million
Q1 2024 May 23, 2024	BUY	$592.2 - $792.28 $71,064 - $95,073	120 Added 0.88%	13,732 $10.7 Million
Q1 2024 May 23, 2024	SELL	$592.2 - $792.28 $71,064 - $95,073	-120 Reduced 0.87%	13,612 $10.6 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $71,064 - $95,073	120 Added 0.88%	13,732 $10.7 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $222,155 - $261,891	423 Added 3.21%	13,612 $7.93 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $291,683 - $402,130	-671 Reduced 4.84%	13,189 $7.08 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $21,395 - $28,607	61 Added 0.44%	13,860 $6.5 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $3,727 - $4,377	12 Added 0.09%	13,799 $4.74 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $26,688 - $31,097	83 Added 0.61%	13,787 $5.04 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $219,395 - $250,023	-740 Reduced 5.12%	13,704 $4.43 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $387,155 - $454,578	-1,389 Reduced 8.77%	14,444 $4.68 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $2,816 - $3,499	12 Added 0.08%	15,833 $4.53 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $2,698 - $3,348	12 Added 0.08%	15,821 $4.37 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $41,882 - $51,542	-189 Reduced 1.18%	15,809 $3.65 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $2,166 - $2,802	12 Added 0.08%	15,998 $3.67 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $244,343 - $316,314	-1,487 Reduced 8.51%	15,986 $2.99 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $11,089 - $14,673	-85 Reduced 0.48%	17,473 $2.95 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $2,339 - $2,706	16 Added 0.09%	17,558 $2.6 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $11,459 - $13,791	-84 Reduced 0.48%	17,542 $2.88 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $2,023 - $2,504	17 Added 0.1%	17,626 $2.45 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $1.88 Million - $2.33 Million	17,609 New	17,609 $2.31 Million
Q3 2019 Nov 05, 2019	SELL	$106.79 - $116.16 $1.88 Million - $2.04 Million	-17,574 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $18,501 - $21,596	167 Added 0.96%	17,574 $1.95 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $1,780 - $2,096	16 Added 0.09%	17,407 $2.26 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $1.43 Million - $1.6 Million	13,515 Added 348.68%	17,391 $2.01 Million
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $1,373 - $1,716	16 Added 0.41%	3,876 $416,000
Q2 2018 Aug 02, 2018	BUY	$75.7 - $86.88 $1,514 - $1,737	20 Added 0.52%	3,860 $329,000
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $1,632 - $1,927	22 Added 0.58%	3,840 $0
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $1,474 - $1,582	18 Added 0.47%	3,818 $322,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $292,866 - $325,052	3,800	3,800 $0

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.

Account

Wellington Shields & Co., LLC Eli Lilly & CO Transaction History